Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain

Author： Clemens Katri Elina   Mikus Gerd  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.2, 2010-02, pp. : 297-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxycodone/Naloxone in the Management of Patients with Pain and Opioid–Induced Bowel Dysfunction

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 124-135

Bentham Science Publishers

Access to resources Recommend Favorite

Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain – results from a large observational study

By Hermanns Kai   Junker Uwe   Nolte Thomas  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 299-311

Informa Healthcare

Access to resources Recommend Favorite

Lubiprostone for the treatment of opioid-induced bowel dysfunction

By Wong Banny S   Camilleri Michael  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 6, 2011-04 ,pp. : 983-990

Informa Healthcare

Access to resources Recommend Favorite

Prolonged-release Oxycodone/Naloxone in Postoperative Pain Management: from a Randomized Clinical Trial to Usual Clinical Practice

By Kuusniemi K   Zöllner J   Sjövall S   Huhtala J   Karjalainen P   Kokki M   Lemken J   Oppermann J   Kokki H  

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 1775-1793

Field House Publishing

Access to resources Recommend Favorite

Oxycodone combined with opioid receptor antagonists: efficacy and safety

By Davis Mellar   Goforth Harold W   Gamier Pam  

Expert Opinion on Drug Safety, Vol. 12, Iss. 3, 2013-05 ,pp. : 389-402

Informa Healthcare

Access to resources Recommend Favorite